Jyong Biotech Ltd. Ordinary Shares
Price Action
Technical Summary
DOWNTRENDJyong Biotech Ltd. Ordinary Shares is in a technical downtrend, trading below key resistance levels with a broken trend structure. Relative strength is weak (RS Rating: 12), showing significant lag compared to the market leaders. Earnings growth of 37% provides fundamental context to the price action. Investors should exercise caution due to high volatility (180% annualized), which requires wider risk management.
Trend Template (Minervini)
Price vs Moving Averages
| Period | Value | Spread | Signal |
|---|---|---|---|
| 20 SMA | $1.83 | +2.86% | ABOVE |
| 50 SMA | $2.03 | -7.52% | BELOW |
| 100 SMA | $2.08 | -9.72% | BELOW |
| 150 SMA | $5.65 | -66.75% | BELOW |
| 200 SMA | $16.91 | -88.88% | BELOW |
Price Performance
Technical Indicators
Risk Profile
Volume Analysis
Earnings Momentum
Growth Trends
Compounded Sales Growth
Compounded Profit Growth
Stock Price CAGR
Return on Equity
Key Metrics
Frequently Asked Questions
Is MENS in an uptrend right now?
MENS has a trend score of 0/4 based on Minervini's Stage Analysis. Currently showing broken structure - 0 of 4 trend criteria are met.
Is MENS overbought or oversold?
MENS's RSI (14) is 52. The stock is in neutral territory, neither overbought nor oversold.
Is MENS outperforming the market?
MENS has a Relative Strength (RS) Rating of 12 out of 99. MENS is currently lagging the broader market.
Where is MENS in its 52-week range?
MENS is trading at $1.88, which is 3% of its 52-week high ($67.00) and 1% above its 52-week low ($1.43).
How volatile is MENS?
MENS has a Beta of 2.11 and 52-week volatility of 180%. It's more volatile than the S&P 500 - expect bigger swings.